Featured Articles

  1. For The Record: An Overview Of CAR-T Trials By Clinical Phase Of Development For Hematological And Solid Tumors 12/6/2023

    Cell therapies have become a highly active area of clinical development in oncology with CAR-T therapies being the most advanced. The first CAR-T therapies were approved in the U.S. in 2017, followed by approvals in the EU and Japan in 2018 and 2019 respectively. China had its first approval in 2021.

  2. Stroke Epidemiology And Its Effect On Patients 12/6/2023

    A stroke occurs when blood flow to a certain area of the brain is cut off, and it can happen to anyone at any time. When this happens, the brain cells are deprived of oxygen and begin to die. As this occurs, different functional abilities such as memory, muscle movements, and speech could be lost depending on the location of the stroke in the brain.

  3. The Fight Against Disparities In Cancer Care 12/6/2023

    September 2023 marked the first ever Oracle Health Conference following the acquisition of Cerner. Co-located in Las Vegas with Oracle CloudWorld, there were over 16,300 attendees, from over 150 countries, with 180 Oracle Health Conference sessions, and over 1000 Oracle CloudWorld sessions (in both digital and in-person formats). It was evident that Oracle is uniquely positioned to serve the evolving needs of the healthcare and life sciences communities.

  4. Enhancing The Healthcare Continuum – A Reflection On The Oracle Health Conference 12/6/2023

    The 2023 Oracle Health Conference unveiled endless opportunities to innovate in healthcare and improve the life’s of patients.

  5. What Is Missing From The Current Business Model Of Pharma Companies? 12/6/2023

    In a panel discussion held at the World Orphan Drug Conference, life science industry leaders delved into the importance of collaboration and shared knowledge in improving patient outcomes.

  6. Getting To The Heart Of The Matter 12/6/2023

    As humans, we like to think that we are rational, that we make logical decisions. We particularly like to think that those responsible for our health, healthcare professionals, are rational and that they will make the best possible decisions on our behalf.

  7. Stigma: A Vicious Circle Of Burden For Sufferers 12/6/2023

    The experience of people suffering from irritable bowel syndrome (IBS) is often fraught with stigma, confusion, embarrassment, belittlement, and loneliness. Cerner Enviza conducted qualitative research with IBS sufferers in UK, US, Germany and China to learn more about the experiences of living with IBS.

  8. We Need To Better Understand The Emotional Impact Of Cancer 12/6/2023

    A cancer diagnosis can put a huge psychological burden on patients and their caregivers. Cerner Enviza is collaborating on a research study with the National Cancer Centre Singapore (NCCS) to better understand this issue and help to advance cancer care.

  9. United BioSource, LLC Selects Oracle Argus Cloud, Paves Path Forward For Future Safety Technology 12/6/2023

    Safety is the cornerstone of clinical trials but capturing and reporting adverse events is a challenge.

  10. EU Set To Attract More Clinical Trials With Streamlined Submission Process 8/25/2021

    Patients can be assured that their prescribed medicine has been vetted for safety and efficacy by a long and arduous discovery process guided by governmental regulatory agencies. The European Union (EU) recorded a concerning 25% decrease in clinical trial applications (CTAs) from 2007 to 2011, and this downward trend has continued. Find out why.